Browsing O - Articles científics by Title

1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test

Lema Calidonio, Camila; Andres Villarreal, Mireia; Aguade Bruix, Santiago; Consegal Perez, Marta; Rodríguez Sinovas, Antonio; Benito Villabriga, Begoña; Ferreira González, Ignacio; Barba Vert, Ignasi (Nature Research, 2020-10-20)

30-Day Mortality Following Palliative Radiotherapy

Vázquez Varela, Miriam; Altabas González, Manuel; Moreno, Diana C; Geng Cahuayme, Abraham Andre Artu; Pérez Hoyos, Santiago; Giralt López de Sagredo, Jordi (Frontiers Media, 2021-04-23)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Coignard, Juliette; Lush, Michael; Beesley, Jonathan; O'Mara, Tracy A.; Dennis, Joe; Tyrer, Jonathan P.; Diez Gibert, Orland; Lopez Fernandez, Adrià (Nature Research, 2021-02-17)

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients

Lozano, Maria L.; Mingot-Castellano, M.E.; Perera, María M.; Jarque, Isidro; Campos-Alvarez, Rosa M.; González-López, Tomás José; Valcarcel Ferreiras, David (Elsevier, 2021-02)

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

Wagner, Alex H.; Walsh, Brian; Mayfield, Georgia; Tamborero, David; Sonkin, Dmitriy; Krysiak, Kilannin; Dienstmann, Rodrigo (Nature Research, 2020-04)

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

Pascual, Tomás; Martin, Miguel; Fernández-Martínez, Aranzazu; Paré, Laia; Alba, Emilio; Rodríguez-Lescure, Álvaro; Cortés Castan, Javier (Frontiers Media, 2019-04-26)

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors

Poveda, Andres; Oaknin benzaquen, Ana Mazaltob; Romero, Ignacio; Guerrero‑Zotano, Angel; Fariñas Madrid, Lorena; Rodriguez‑Freixinos, Victor (Nature Research, 2021-02-24)

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

Schmid, Peter; Sablin, Marie-Paule; Bergh, Jonas; Im, Seock-Ah; Lu, Yen-Shen; Martínez, Noelia; Cortés Castan, Javier (BMC, 2021-01-15)

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

Yamamoto, Nobuyuki; Hayashi, Hidetoshi; Planchard, David; Morán, Teresa; Gregorc, Vanesa; Dowell, Jonathan; Cedres Perez, Susana (Springer, 2020-10)

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

Gunda, Aparna; Basavaraj, Chetana; Serkad, Chandra Prakash V; Adinarayan, Manjula; Kolli, Ramu; Siraganahalli Eshwaraiah, Mallikarjuna; Saura Manich, Cristina; Ruiz Pace, Fiorella; Gómez Pardo, Patricia; Peg Camara, Vicente; Jiménez Flores, José Antonio (Elsevier, 2022-06)

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Johnston, Stephen RD; Harbeck, Nadia; Hegg, Roberto; Toi, Masakazu; Martin, Miguel; Shao, Zhi Min; Cortés Castan, Javier (American Society of Clinical Oncology, 2020-12-01)

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation

Arenas Lahuerta, Enrique Javier; Martínez-Sabadell, Alex; Rius Ruiz, Irene; Román Alonso, Macarena; Escorihuela Baez, Marta; Luque García, Antonio; Fajardo, Carlos Alberto; Gros Vidal, Alena; Arribas López, Joaquin Vicente (Nature Research, 2021-02-23)

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report

Mirallas Viñas, Oriol; Saoudi Gonzalez, Nadia; Gomez-Puerto, Diego; Riveiro Barciela, Maria del Mar; Merino Casabiel, Xavier; Auger Acosta, Cristina; Landolfi, Stefania; Blanco Cuso, Laia; García Burillo, Amparo; Molero Richard, Francesc Xavier; Salcedo Allende, Maria Teresa; Capdevila Castillon, Jaume (Baishideng Publishing Group, 2021-05-27)

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

Döhner, Hartmut; Symeonidis, Argiris; Deeren, Dries; Demeter, Judit; Sanz, Miguel A.; Anagnostopoulos, Achilles; Salamero García, Olga (Wolters Kluwer Health, 2021-08)

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Harbeck, Nadia; Rastogi, P.; Martin, M.; Tolaney, Sara M; Shao, Zhi Min; Fasching, P. A.; Cortés Castan, Javier (Elsevier, 2021-12)

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors

Neeb, Antje; Herranz Martín, Nicolás; Arce Gallego, Sara; Miranda, Susana; Buroni, Lorenzo; Yuan, Wei; Athie Cuervo, Alejandro; Casals, Teresa; Casanova Salas, Irene; Cordoba, Sarai; Castro, Natalia; González Rodríguez, Macarena; Morales Barrera, Rafael; Suárez Rodríguez, Cristina; Carles Galceran, Joan; Serra Elizalde, Violeta; Mateo Valderrama, Joaquim (Elsevier, 2021-02)

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

Goss, Glenwood D.; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Felip Font, Enriqueta (Elsevier, 2021-07)

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report

Mirallas Viñas, Oriol; Filippi Arriaga, Maria Francesca Eugenia; Hernández Hernández, Irene; Aubanell, Anton; Chaachou, Anas; Garcia-Alvarez, Alejandro; Hernando Cubero, Jorge; Martinez Saez, Elena Antima; Biagetti Biagetti, Betina; Capdevila Castillon, Jaume (Frontiers Media, 2021-11-11)

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Barbui, Tiziano; De Stefano, Valerio; Alvarez-Larran, Alberto; Iurlo, Alessandra; Masciulli, Arianna; Carobbio, Alessandra; Fox, Maria Laura (Springer Nature, 2021-02-04)

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

Carles Galceran, Joan; Pichler, Angelika; Korunkova, Hana; Tomova, Antoaneta; Ghosn, Marwan; El Karak, Fadi (Wiley, 2019-03-01)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Browsing VHIO - Articles científics by Title

1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test

30-Day Mortality Following Palliative Radiotherapy

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

Know Scientia

Guides and help

Go to...

Know Scientia

Guides and help

Go to...

Browsing VHIO - Articles científics by Title

1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test ﻿

30-Day Mortality Following Palliative Radiotherapy ﻿

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers ﻿

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients ﻿

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer ﻿

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer ﻿

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors ﻿

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer ﻿

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer ﻿

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort ﻿

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE) ﻿

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation ﻿

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report ﻿

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial ﻿

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study ﻿

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors ﻿

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial ﻿

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report ﻿

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 ﻿

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA) ﻿

Know Scientia

Guides and help

Go to...

Know Scientia

Guides and help

Go to...

1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test

30-Day Mortality Following Palliative Radiotherapy

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors

A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case report

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA)